Clovis Oncology Inc (CLVS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0812 -0.0048 (-5.58%) 12/20/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.0812 unch (unch) -
for Tue, Dec 20th, 2022
Results
download Want to compare other data? Select Fields| Symbol | CLVS | SYBX | ABVC | ||
| Company | Clovis Oncology Inc | Synlogic Inc | Abvc Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0808 | 1.2000 | 1.0000 | ||
| High | 0.0977 | 1.2000 | 1.0600 | ||
| Low | 0.0766 | 1.0500 | 0.9201 | ||
| Last | 0.0812 | 1.1200 | 1.0000 | ||
| Change | -0.0048 | -0.0440 | +0.0235 | ||
| % Change | -5.58% | -3.78% | +2.41% | ||
| Volume | 24,516,400 | 9,800 | 260,600 | ||
| 20-Day Average Volume | 9,433,500 | 14,010 | 657,800 | ||
| Previous Close | 0.0860 | 1.1640 | 0.9765 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 1.1046 | 0.9462 | ||
| 20-Day Raw Stochastic | 1.73% | 58.12% | 40.30% | ||
| 20-Day Relative Strength | 23.83% | 44.91% | 57.07% | ||
| Weighted Alpha | -91.19 | -39.73 | -15.19 | ||
| Today's Opinion | 100% Sell | 88% Sell | 88% Buy | ||
| Previous Opinion | 100% Sell | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +5.65% since 04/21/25 | +14.56% since 04/21/25 | ||
| Low | 0.0760 on 12/16/22 | 1.0500 on 04/28/25 | 0.8060 on 04/23/25 | ||
| High | 0.1439 on 12/14/22 | 1.2000 on 04/28/25 | 1.0600 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -12.50% since 03/28/25 | +16.28% since 03/28/25 | ||
| Low | 0.0760 on 12/16/22 | 0.8980 on 04/09/25 | 0.7300 on 04/07/25 | ||
| High | 0.3772 on 12/01/22 | 1.2800 on 03/31/25 | 1.4000 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -20.57% since 01/28/25 | +86.92% since 01/28/25 | ||
| Low | 0.0760 on 12/16/22 | 0.8980 on 04/09/25 | 0.4000 on 02/10/25 | ||
| High | 1.3100 on 10/04/22 | 1.4890 on 01/29/25 | 1.4000 on 04/01/25 | ||
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -21.13% since 10/28/24 | +35.14% since 10/28/24 | ||
| Low | 0.0760 on 12/16/22 | 0.8980 on 04/09/25 | 0.4000 on 02/10/25 | ||
| High | 3.2500 on 07/08/22 | 1.8800 on 12/11/24 | 1.4000 on 04/01/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 12,632 | 11,707 | ||
| Shares Outstanding, K | 144,955 | 11,696 | 15,778 | ||
| Annual Sales | 148,760,000 | 10,000 | 510,000 | ||
| Annual Net Income | -264,520,000 | -23,360,000 | -4,900,000 | ||
| Last Quarter Sales | 30,660,000 | 0 | 390,000 | ||
| Last Quarter Net Income | -56,010,000 | 6,310,000 | -190,000 | ||
| 60-Month Beta | 0.24 | 0.69 | 0.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | -0.06 on 03/06/25 | 0.04 on 04/15/25 | ||
| Latest Earnings Date | 11/09/22 | 05/13/25 | 05/16/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||